ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Pittsburgh, PA, USA:

Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Pittsburgh, Pennsylvania, United States and 108 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 123 other locations

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Smithfield, Pennsylvania, United States and 20 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Pittsburgh, Pennsylvania, United States and 214 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Pittsburgh, Pennsylvania, United States and 59 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:Are age <21 y...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Pittsburgh, Pennsylvania, United States and 35 other locations

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19...

Active, not recruiting
SARS-CoV-2 Infection
Drug: S-217622
Drug: Placebo

Phase 3

Shionogi
Shionogi

Pittsburgh, Pennsylvania, United States and 188 other locations

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Enrolling
SARS-CoV-2
Other: Placebo
Biological: mRNA-1273.214

Phase 2

Moderna
Moderna

Pittsburgh, Pennsylvania, United States and 51 other locations

This study will enroll individuals who have:Completed primary series of mRNA COVID-19 vaccine, andAn antibody response ≤ 2500 U/mL -...

Active, not recruiting
Liver Transplant Recipients
Kidney Transplant Recipients
Biological: Moderna COVID-19 Vaccine 2023-2024
Biological: Pfizer-BioNTech COVID-19 Vaccine 2023-2024

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 14 other locations

chain reaction [RT-PCR] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo t...

Enrolling
SARS-CoV-2 Infection
Drug: Placebo
Drug: S-217622

Phase 3

Shionogi
Shionogi

Scottdale, Pennsylvania, United States and 97 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems